ALAVERT ODT OTC
Generic Name and Formulations:
Loratadine 10mg; orally-disintegrating tabs; contains phenylalanine; fresh mint, citrus burst, bubble gum flavors.
Indications for ALAVERT ODT:
Allergic rhinitis (seasonal).
Adults and Children:
<6yrs: not recommended. ≥6yrs: Dissolve on tongue; swallow with or without water. 10mg once daily.
Hepatic or renal impairment. Pregnancy. Nursing mothers.
Adults: headache, somnolence, fatigue, dry mouth. Children: nervousness, wheezing, hyperkinesia, abdominal pain, conjunctivitis, dysphonia, malaise, upper respiratory infections.
Hepatic (CYP3A4, 2D6).
ODT—12, 24, 48
Endocrinology Advisor Articles
- Effect of HbA1c and Perioperative Glucose on Postoperative Mortality
- GLP-1 Agonists Superior to DPP-4 Inhibitors for Reducing HbA1c, Weight in T2D
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Effect of Growth Hormone Treatment on BMD in Adults With Prader-Willi Syndrome
- Once-Daily Oral Contraceptive for Men Shows Promise
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Metformin May Improve Pregnancy Outcomes in Polycystic Ovary Syndrome
- HbA1c Levels Affect Serum Phospholipids, Inflammation inT2D, CVD
- No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia
- Cardiovascular Function May Improve After Cure of Cushing Syndrome
- Primary Prevention Outcomes With Aspirin in T2D and Heart Failure